
Abbott Laboratories
NYSE:ABT

Intrinsic Value
The intrinsic value of one
ABT
stock under the Base Case scenario is
105.37
USD.
Compared to the current market price of 130.88 USD,
Abbott Laboratories
is
Overvalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Abbott Laboratories
Fundamental Analysis

Revenue & Expenses Breakdown
Abbott Laboratories
Balance Sheet Decomposition
Abbott Laboratories
Current Assets | 23.7B |
Cash & Short-Term Investments | 8B |
Receivables | 6.9B |
Other Current Assets | 8.8B |
Non-Current Assets | 57.8B |
Long-Term Investments | 886m |
PP&E | 10.7B |
Intangibles | 29.8B |
Other Non-Current Assets | 16.5B |
Free Cash Flow Analysis
Abbott Laboratories
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Abbott Laboratories
Revenue
|
42.3B
USD
|
Cost of Revenue
|
-18.6B
USD
|
Gross Profit
|
23.8B
USD
|
Operating Expenses
|
-16.4B
USD
|
Operating Income
|
7.4B
USD
|
Other Expenses
|
6.1B
USD
|
Net Income
|
13.5B
USD
|
ABT Profitability Score
Profitability Due Diligence
Abbott Laboratories's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
Abbott Laboratories's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
ABT Solvency Score
Solvency Due Diligence
Abbott Laboratories's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Score
Abbott Laboratories's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABT
is 144.01 USD
with a low forecast of 112.45 USD and a high forecast of 166.95 USD.
Dividends
Current shareholder yield for ABT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ABT
stock under the Base Case scenario is
105.37
USD.
Compared to the current market price of 130.88 USD,
Abbott Laboratories
is
Overvalued by 19%.